Sutro Biopharma Inc. (STRO)
26.09
+0.30 (1.16%)
Upcoming Events
Latest Headlines
Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: Wigginton Jon Marc
June 9, 2026 4:25 PM - SEC Filing
Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: Petree Daniel H
June 9, 2026 4:24 PM - SEC Filing
Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: PANEK JAMES P
June 9, 2026 4:22 PM - SEC Filing
Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: Lobacki Joseph M
June 9, 2026 4:20 PM - SEC Filing
Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: Jagpal Sukhi
June 9, 2026 4:18 PM - SEC Filing
Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: Hunter Heidi
June 9, 2026 4:17 PM - SEC Filing
Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: Dybbs Michael
June 9, 2026 4:15 PM - SEC Filing
Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: MATSUI CONNIE
June 9, 2026 4:13 PM - SEC Filing
Form 8-K SUTRO BIOPHARMA, INC. For: Jun 05
June 8, 2026 4:01 PM - SEC Filing
Form 4 SUTRO BIOPHARMA, INC. For: Jun 02 Filed by: Chow Gregory K.
June 2, 2026 4:16 PM - SEC Filing
Barclays initiates oncology-focused biotechs with positive outlook
May 28, 2026 11:05 AM - StreetInsider
Barclays Starts Sutro Biopharma (STRO) at Overweight
May 28, 2026 3:36 AM - StreetInsider
Form SCHEDULE 13G SUTRO BIOPHARMA, INC. Filed by: Samsara BioCapital, L.P.
May 15, 2026 4:45 PM - SEC Filing
Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: Kynam Capital Management, LP
May 15, 2026 4:02 PM - SEC Filing
Wedbush Upgrades Sutro Biopharma (STRO) to Outperform
May 15, 2026 6:34 AM - StreetInsider
Sutro Biopharma Inc. (STRO) Misses Q1 EPS by 294c
May 14, 2026 4:56 PM - StreetInsider
Form 10-Q SUTRO BIOPHARMA, INC. For: Mar 31
May 14, 2026 4:31 PM - SEC Filing
Form 8-K SUTRO BIOPHARMA, INC. For: May 14
May 14, 2026 4:16 PM - SEC Filing
Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: Affinity Asset Advisors, LLC
May 14, 2026 4:14 PM - SEC Filing
Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights
May 14, 2026 4:05 PM - Globe NewsWire
Form SCHEDULE 13G SUTRO BIOPHARMA, INC. Filed by: Point72 Asset Management, L.P.
May 1, 2026 4:11 PM - SEC Filing
Mizuho Starts Sutro Biopharma (STRO) at Outperform
April 30, 2026 5:12 AM - StreetInsider
Sutro Biopharma (STRO) PT Raised to $41 at Citizens
April 23, 2026 8:51 AM - StreetInsider
Form ARS SUTRO BIOPHARMA, INC. For: Dec 31
April 22, 2026 5:01 PM - SEC Filing
Form DEFA14A SUTRO BIOPHARMA, INC.
April 22, 2026 4:16 PM - SEC Filing
Form DEF 14A SUTRO BIOPHARMA, INC. For: Jun 05
April 22, 2026 4:06 PM - SEC Filing
Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: MILLENNIUM MANAGEMENT LLC
April 21, 2026 5:49 PM - SEC Filing
Form SCHEDULE 13G SUTRO BIOPHARMA, INC. Filed by: PERCEPTIVE ADVISORS LLC
April 21, 2026 4:19 PM - SEC Filing
Sutro Biopharma presents preclinical data on ADC programs at AACR
April 19, 2026 7:45 PM - StreetInsider
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
April 19, 2026 7:45 PM - Globe NewsWire
Sutro Biopharma (STRO) PT Raised to $35 at Citizens Ahead of AACR Conference
April 17, 2026 7:19 AM - StreetInsider
Leerink Partners Starts Sutro Biopharma (STRO) at Outperform
April 7, 2026 6:03 AM - StreetInsider
Form EFFECT SUTRO BIOPHARMA, INC.
April 2, 2026 6:07 AM - SEC Filing
Form 424B3 SUTRO BIOPHARMA, INC.
April 1, 2026 5:19 PM - SEC Filing
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
March 24, 2026 9:53 AM - Globe NewsWire
H.C. Wainwright Upgrades Sutro Biopharma (STRO) to Buy
March 24, 2026 6:09 AM - StreetInsider
Sutro Biopharma (STRO) Reiterated at Market Outperform by Citizens: 'Shares Undervalued'
March 24, 2026 4:35 AM - StreetInsider
Wells Fargo Upgrades Sutro Biopharma (STRO) to Overweight
March 24, 2026 4:05 AM - StreetInsider
Sutro Biopharma Inc. (STRO) files $300M mixed shelf
March 23, 2026 5:32 PM - StreetInsider
Form S-3 SUTRO BIOPHARMA, INC.
March 23, 2026 5:23 PM - SEC Filing
Form S-8 SUTRO BIOPHARMA, INC.
March 23, 2026 5:11 PM - SEC Filing
Form 10-K SUTRO BIOPHARMA, INC. For: Dec 31
March 23, 2026 4:45 PM - SEC Filing
Form 8-K SUTRO BIOPHARMA, INC. For: Mar 23
March 23, 2026 4:33 PM - SEC Filing
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
March 23, 2026 4:05 PM - Globe NewsWire
Full Article List
